Regeneron CEO: Trump's use of drug 'weakest evidence' of any success - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Regeneron CEO says Trump's experience with the company's COVID-19 drug is the 'weakest evidence you can get' of whether it works

"The president's case is a case of one, and that's what we call a case report," said Schleifer. He added that there were some interesting aspects of Trump's case, including the fact that "he was elderly, [and] he had some risk factors."Trump received 8 grams of Regeneron's drug, REGN-COV2,In September, Regeneron said its treatment has been able to improve virus symptoms in non-hospitalized patients.

The antibody cocktail has yet to receive emergency FDA approval, but the government has struck a deal for 300,000 doses. If the drug is approved for emergency approval, only 50,000 doses will be available.

"We have tried to take a principled approach until there is a broader authorization," said Schleifer during the same interview. "Asking somebody like the president to go into a clinical trial just wasn't practical."

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Trumps experience is such weak evidence for regeneron efficacy that it simply should be classed as evidence. I do hope regeneron’s CEO realises that it’s not even on the bottom run of the ladder!

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 729. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Singapore Airlines fine-dining restaurant inside aircraft sells out - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. why?
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »

Inside the investment portfolio of a millennial homeowner - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »

SUCCESS INSIDER: Management consulting, Daymond John, side hustles - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. By cutting scheduled raises, and putting massive amounts of workload on 1st years.
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »

Trump: Favor-seekers benefit after spending big at his businesses: NYT - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »

How a memo made Coinbase into exactly what its CEO wanted to avoid - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. brian_armstrong chainlink $link If that worked get rid of the all the troublemakers, good idea, needs to become a corporate standard. (No comment on the business of the company). Lol, COinbase is a joke. US people doesnt like them at all.
Sumber: BusinessInsider - 🏆 729. / 51 Baca lebih lajut »